Table 2.
Study Type | Characteristics of Study Participants | Intervention | Outcome | References |
---|---|---|---|---|
Prospective | 39 terminal cancer patients | 10 g IVC twice with a 3-day interval in the first week, followed by oral intake of 4 g daily for one week | Reduced intensity of pain after IVC treatment | Yeom et al. [120] |
Prospective | 60 patients with newly diagnosed cancer, anti-cancer therapy administered in 34 patients | 4 weeks of IVC therapy, median single dose 50 g (range 25–100 g) | Reduced intensity of pain after IVC treatment | Takahashi et al. [102] |
Prospective | 17 patients with advanced solid tumors refractory to standard therapy | IVC for 4 consecutive days a week for 4 weeks, starting at 30 g/m2, increased until a maximum tolerated dose (110 g/m2) | Reduced intensity of pain during IVC with complete pain relief after 4 weeks of IVC therapy | Stephenson et al. [28] |
Controlled retrospective | 39 patients with bone metastases, radiotherapy-resistant (n = 15 on chemotherapy; n = 15 on IVC therapy; n = 9 controls) |
IVC group: 2.5 g IVC during pain | Median 50% reduction in pain intensity in IVC group | Günes-Bayir et al. [123] |
Uncontrolled retrospective | 11 cancer patients with bone metastases, unresponsive to standard cancer treatment | IVC 2.5 g once weekly for 3–10 weeks | Mean 55% reduction in pain intensity | Kiziltan et al. [138] |
Case study | A female aged 53 with breast carcinoma with visceral and skeletal metastases, after mastectomy, radiotherapy, and hormonotherapy, terminal state with severe pain requiring opioids | 5 g IVC for 7 days, followed by 8 g daily for 70 days orally (total 595 g) | Complete relief from bone pain Reduced need for opioids |
Cameron and Campbell [7] |
A male aged 44 with poorly differentiated transitional cell cancer of bladder with bone metastases, intense pain inadequately controlled by opioids | 10 g IVC for 10 days, followed by 10 g daily for 24 days orally (total 340 g) | Complete relief from bone pain No further need for opioids |
Cameron and Campbell [7] | |
A female 49 with disseminated carcinoma of unknown origin, innumerable osteolytic bone metastases, severe bone pain | 10 g IVC for 7 days, followed by 10 g daily for 27 days orally (total 340 g) | Complete relief from bone pain | Cameron and Campbell [7] | |
A male aged 49 with large malignant tumor of right temporal lobe, unknown histology, intolerable headache | 10 g IVC for 11 days, followed by 10 g daily for 2 days orally (total 360 g) | Significant relief from headache | Cameron and Campbell [7] | |
Case study | A female aged 45 with recurrent breast cancer | 50 g IVC twice a week for 4 weeks | Reduction in pain intensity | Carr et al. [121] |
Case study | A male aged 81 with recurrent pulmonary angiosarcoma | 30 g IVC daily for 1 week | Reduction in pain intensity | Carr et al. [122] |